| Lundbeck (Schweiz) AG - Vyepti 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 67995 | | 02 | | Vyepti 300 mg/3 ml | | Konzentrat zur Herstellung einer Infusionslösung | | N02CD05 | | Eptinezumab | | 13.08.2026 | | |
|
| Composition |
| eptinezumabum 300 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 121.5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Eptinezumabum | 300mg / 3ml |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Polysorbatum 80 | | | Sorbitol | 121.5mg / 3ml |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 3 ml | | | B | | Yes |
|
